Identification of Nicotinamide N-Methyltransferase as a Novel Tumor Marker for Renal Clear Cell Carcinoma
is companion of
Abstract
Purpose:
To explore the involvement of enzymes of drug metabolism in renal cell carcinoma we analyzed the gene expression profiles of tumor and nontumor tissues from the same patient by DNA macroarray. The enzyme nicotinamide N-methyltransferase was selected for further evaluation.
Materials and Methods:
Nicotinamide N-methyltransferase mRNA expression was investigated in paired tissue samples from cancerous and noncancerous parts of the kidneys of 30 patients with clear cell renal cell carcinoma who underwent tumor nephrectomy. Measurements were performed by semiquantitative reverse transcriptase-polymerase chain reaction and quantitative real-time polymerase chain reaction. Paired tissue samples were also obtained from 1 patient with chromophobe renal cell carcinoma and from another with oncocytoma to compare the specificity of changes in nicotinamide N-methyltransferase expression among tumors that are related to different renal epithelial cell types. Western blot analysis and catalytic activity assay were also performed to study nicotinamide N-methyltransferase expression. Expression correlated with tumor characteristics.
Results:
A marked increased expression in tumor tissue was found for nicotinamide N-methyltransferase, which is an enzyme involved in the biotransformation of many drugs and xenobiotic compounds. Differential gene expression measurements in tumor vs normal tissue revealed up-regulation in all clear cell renal cell carcinomas at between 3 and 294-fold (mean 41). In contrast, in chromophobe renal cell carcinoma and oncocytoma nicotinamide N-methyltransferase expression did not increase. In addition, nicotinamide N-methyltransferase expression significantly correlated inversely with tumor size.
Conclusions:
Our results indicate that a marked nicotinamide N-methyltransferase increase is a peculiar feature of clear cell renal cell carcinoma. Additional studies may establish the role of nicotinamide N-methyltransferase in tumor formation and progression.
References
- 1 : Novel treatment strategies in clear-cell metastatic renal cell carcinoma. Anticancer Drugs2005; 16: 709. Google Scholar
- 2 : Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res2004; 64: 4117. Google Scholar
- 3 : Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene2003; 22: 6810. Google Scholar
- 4 : Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma. BJU Int2005; 96: 281. Google Scholar
- 5 : Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell2004; 6: 129. Google Scholar
- 6 : Human liver nicotinamide N-methyltransferase: ion-pairing radiochemical assay, biochemical properties and individual variation. Clin Chim Acta1989; 186: 359. Google Scholar
- 7 : Human liver nicotinamide N-methyltransferase: cDNA cloning, expression, and biochemical characterization. J Biol Chem1994; 269: 14835. Google Scholar
- 8 : Human nicotinamide N-methyltransferase gene: molecular cloning, structural characterization and chromosomal localization. Genomics1995; 29: 555. Google Scholar
- 9 : Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol1982; 6: 655. Crossref, Medline, Google Scholar
- 10 : Assay methods for nicotinamide mononucleotide adenylyltransferase of wide applicability. Anal Biochem1995; 228: 64. Google Scholar
- 11 : A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem1976; 72: 248. Google Scholar
- 12 : Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol2005; 173: 1496. Link, Google Scholar
- 13 : Autotoxicity, methylation and a road to the prevention of Parkinson’s disease. J Clin Neurosci2005; 12: 6. Google Scholar
- 14 : Differential gene expression profiling in human brain tumors. Physiol Genomics2001; 5: 21. Google Scholar
- 15 : The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res2004; 14: 491. Google Scholar
- 16 : Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells. J Clin Endocrinol Metab2003; 88: 4990. Google Scholar
- 17 : Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells. Mol Endocrinol2005; 19: 527. Google Scholar
- 18 : Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J Pathol2005; 205: 377. Google Scholar
- 19 : Nicotinamide homeostasis: a xenobiotic pathway that is key to development and degenerative diseases. Med Hypoth2005; 65: 353. Google Scholar
- 20 : Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked?. Bioessays2003; 25: 808. Google Scholar
